JULIE GASTIER-FOSTER to Cell Line, Tumor
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Cell Line, Tumor.
Connection Strength
0.521
-
Integrated Genomic Analysis of the Ubiquitin Pathway across Cancer Types. Cell Rep. 2018 04 03; 23(1):213-226.e3.
Score: 0.090
-
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers. Cell Rep. 2018 04 03; 23(1):227-238.e3.
Score: 0.090
-
Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types. Cell Rep. 2018 04 03; 23(1):282-296.e4.
Score: 0.045
-
Transcriptome analysis of desmoplastic small round cell tumors identifies actionable therapeutic targets: a report from the Children's Oncology Group. Sci Rep. 2020 07 23; 10(1):12318.
Score: 0.026
-
Genomic Profiling of Childhood Tumor Patient-Derived Xenograft Models to Enable Rational Clinical Trial Design. Cell Rep. 2019 11 05; 29(6):1675-1689.e9.
Score: 0.025
-
Comprehensive Molecular Characterization of the Hippo Signaling Pathway in Cancer. Cell Rep. 2018 10 30; 25(5):1304-1317.e5.
Score: 0.023
-
Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas. Cell Rep. 2018 04 03; 23(1):172-180.e3.
Score: 0.022
-
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. Cell Rep. 2018 04 03; 23(1):194-212.e6.
Score: 0.022
-
Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas. Cell Rep. 2018 04 03; 23(1):239-254.e6.
Score: 0.022
-
Molecular Characterization and Clinical Relevance of Metabolic Expression Subtypes in Human Cancers. Cell Rep. 2018 04 03; 23(1):255-269.e4.
Score: 0.022
-
Pan-Cancer Analysis of lncRNA Regulation Supports Their Targeting of Cancer Genes in Each Tumor Context. Cell Rep. 2018 04 03; 23(1):297-312.e12.
Score: 0.022
-
lncRNA Epigenetic Landscape Analysis Identifies EPIC1 as an Oncogenic lncRNA that Interacts with MYC and Promotes Cell-Cycle Progression in Cancer. Cancer Cell. 2018 04 09; 33(4):706-720.e9.
Score: 0.022
-
Mutational landscape, clonal evolution patterns, and role of RAS mutations in relapsed acute lymphoblastic leukemia. Proc Natl Acad Sci U S A. 2016 10 04; 113(40):11306-11311.
Score: 0.020
-
Relapsed neuroblastomas show frequent RAS-MAPK pathway mutations. Nat Genet. 2015 08; 47(8):864-71.
Score: 0.018
-
A Genome-Wide Scan Identifies Variants in NFIB Associated with Metastasis in Patients with Osteosarcoma. Cancer Discov. 2015 Sep; 5(9):920-31.
Score: 0.018
-
The genetic landscape of high-risk neuroblastoma. Nat Genet. 2013 Mar; 45(3):279-84.
Score: 0.016
-
The genomic landscape of hypodiploid acute lymphoblastic leukemia. Nat Genet. 2013 Mar; 45(3):242-52.
Score: 0.016